280 related articles for article (PubMed ID: 33413573)
1. Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis.
Li W; Deng C; Yang H; Lu X; Li S; Liu X; Chen F; Chen L; Shu X; Zhang L; Liu Q; Wang G; Peng Q
Arthritis Res Ther; 2021 Jan; 23(1):15. PubMed ID: 33413573
[TBL] [Abstract][Full Text] [Related]
2. Human CD4
Šunina M; Alnek K; Kisand K; Uibo R
Scand J Immunol; 2021 Sep; 94(3):e13089. PubMed ID: 35971920
[TBL] [Abstract][Full Text] [Related]
3. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of the CD155-CD226 Axis Is Associated With Muscle Inflammation and Disease Severity in Idiopathic Inflammatory Myopathies.
Li W; Deng C; Yang H; Tian X; Chen L; Liu Q; Gao C; Lu X; Wang G; Peng Q
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37491355
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of the CD226/TIGIT Immune Checkpoint Is Involved in the Pathogenesis of Primary Biliary Cholangitis.
Deng C; Li W; Fei Y; Wang L; Chen Y; Zeng X; Zhang F; Li Y
Front Immunol; 2020; 11():1619. PubMed ID: 32793241
[TBL] [Abstract][Full Text] [Related]
6. The TIGIT/CD226 axis regulates human T cell function.
Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
[TBL] [Abstract][Full Text] [Related]
7. CD8
Wang M; Bu J; Zhou M; Sido J; Lin Y; Liu G; Lin Q; Xu X; Leavenworth JW; Shen E
Clin Immunol; 2018 May; 190():64-73. PubMed ID: 28893624
[TBL] [Abstract][Full Text] [Related]
8. Decrease in CD226 expression on CD4
Li C; Zhou J; Shao J; Yuan L; Cheng Q; Wang L; Duan Z
Biosci Trends; 2023 May; 17(2):168-171. PubMed ID: 37081668
[TBL] [Abstract][Full Text] [Related]
9. Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.
Fuhrman CA; Yeh WI; Seay HR; Saikumar Lakshmi P; Chopra G; Zhang L; Perry DJ; McClymont SA; Yadav M; Lopez MC; Baker HV; Zhang Y; Li Y; Whitley M; von Schack D; Atkinson MA; Bluestone JA; Brusko TM
J Immunol; 2015 Jul; 195(1):145-55. PubMed ID: 25994968
[TBL] [Abstract][Full Text] [Related]
10. CD226 and TIGIT Cooperate in the Differentiation and Maturation of Human Tfh Cells.
Yasutomi M; Christiaansen AF; Imai N; Martin-Orozco N; Forst CV; Chen G; Ueno H
Front Immunol; 2022; 13():840457. PubMed ID: 35273617
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Rezaeepoor M; Behzad M
Immunol Lett; 2020 Sep; 225():1-8. PubMed ID: 32540486
[TBL] [Abstract][Full Text] [Related]
12. CD226 opposes TIGIT to disrupt Tregs in melanoma.
Fourcade J; Sun Z; Chauvin JM; Ka M; Davar D; Pagliano O; Wang H; Saada S; Menna C; Amin R; Sander C; Kirkwood JM; Korman AJ; Zarour HM
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046006
[TBL] [Abstract][Full Text] [Related]
13. Higher TIGIT
Jin Z; Lan T; Zhao Y; Du J; Chen J; Lai J; Xu L; Chen S; Zhong X; Wu X; Li Y
Immunol Invest; 2022 Jan; 51(1):40-50. PubMed ID: 32819181
[TBL] [Abstract][Full Text] [Related]
14. Examination of the TIGIT, CD226, CD112, and CD155 Immune Checkpoint Molecules in Peripheral Blood Mononuclear Cells in Women Diagnosed with Early-Onset Preeclampsia.
Szereday L; Nagy DU; Csiszar B; Kevey D; Feik T; Meggyes M
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829838
[TBL] [Abstract][Full Text] [Related]
15. Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients.
Li C; Liu H; Duan Z
BMC Immunol; 2024 Feb; 25(1):12. PubMed ID: 38326745
[TBL] [Abstract][Full Text] [Related]
16. Perturbed CD8
Tauriainen J; Scharf L; Frederiksen J; Naji A; Ljunggren HG; Sönnerborg A; Lund O; Reyes-Terán G; Hecht FM; Deeks SG; Betts MR; Buggert M; Karlsson AC
Sci Rep; 2017 Jan; 7():40354. PubMed ID: 28084312
[TBL] [Abstract][Full Text] [Related]
17. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
[No Abstract] [Full Text] [Related]
18. Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8
Banta KL; Xu X; Chitre AS; Au-Yeung A; Takahashi C; O'Gorman WE; Wu TD; Mittman S; Cubas R; Comps-Agrar L; Fulzele A; Bennett EJ; Grogan JL; Hui E; Chiang EY; Mellman I
Immunity; 2022 Mar; 55(3):512-526.e9. PubMed ID: 35263569
[TBL] [Abstract][Full Text] [Related]
19. Examination of the TIGIT-CD226-CD112-CD155 Immune Checkpoint Network during a Healthy Pregnancy.
Meggyes M; Nagy DU; Feik T; Boros A; Polgar B; Szereday L
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142692
[No Abstract] [Full Text] [Related]
20. Recovery of CD226-TIGIT
Long Y; Wang C; Xia C; Li X; Fan C; Zhao X; Liu C
Immunol Lett; 2020 Feb; 218():30-39. PubMed ID: 31883787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]